Genomics and additional 'omics' to determine treatment
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
535
NCT03396341
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
Phase: N/A
Role: Collaborator
Start: Jan 4, 2018
Completion: Jan 31, 2026
NCT06814938
A Study of a Novel Precision Medicine Approach for Obesity
Phase: Phase 4
Start: Feb 21, 2025
Completion: Nov 30, 2028
Loading map...